Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
0.9% NaCl isotonic saline solution
- Development stage
- Unknown
- Lead developer
- NeoTrials
- Modality
- Small Molecules
- Administration
- Inhalation, Intravenous
01
Overview
0.9% NaCl isotonic saline solution, commonly known as normal saline, is a sterile, non-pyrogenic solution of sodium chloride in water. It is a pharmacologically inert solution widely used as a placebo or comparator in clinical trials. In a Phase I clinical trial sponsored by NeoTrials Pty Ltd (NCT06662019), it was administered via inhalation as a blinded placebo control to evaluate the safety and tolerability of the investigational drug N-IP-00001 in healthy volunteers.
- Other names
- 0.9% sodium chlorideisotonic normal salineisotonic salinenormal salinenormal saline solutionsaline solution
Beyond the preview
Go deeper on 0.9% NaCl isotonic saline solution.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 0.9% NaCl isotonic saline solution.